DOI: 10.12809/hkmj154509
LETTER TO THE EDITOR
Reversal of warfarin in life-threatening bleeding
Daniel SK Ng, FACEM, FHKAM (Emergency Medicine)
Emergency Department, Swan District Hospital, 1 Eveline Road, Middle Swan, Western Australia 6056
Corresponding author: Dr Daniel SK Ng (daniel.ng@health.wa.gov.au)
 Full paper in PDF
 
To the Editor—I read with interest the article “The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage” by Fong et al in the December 2014 issue of the Hong Kong Medical Journal.1 The Australian guidelines for warfarin reversal quoted in the article were outdated.2 The most recent Australian guidelines can be found in the March 2013 issue of the Medical Journal of Australia.3
 
References
1. Fong WC, Lo WT, Ng YW, et al. The benefit of prothrombin complex concentrate in decreasing neurological deterioration in patients with warfarin-associated intracerebral haemorrhage. Hong Kong Med J 2014;20:486-94. CrossRef
2. Baker RI, Coughlin PB, Gallus AS, Harper PL, Salem HH, Wood EM; Warfarin Reversal Consensus Group. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis. Med J Aust 2004;181:492-7.
3. Tran HA, Chunilal SD, Harper PL, Tran H, Wood EM, Gallus AS; Australasian Society of Thrombosis and Haemostasis (ASTH). An update of consensus guidelines for warfarin reversal. Med J Aust 2013;198:198-9. CrossRef